179 related articles for article (PubMed ID: 9923651)
1. An alpha2(I) glycine to aspartate substitution is responsible for the presence of a kink in type I collagen in a lethal case of osteogenesis imperfecta.
Forlino A; Keene DR; Schmidt K; Marini JC
Matrix Biol; 1998 Dec; 17(8-9):575-84. PubMed ID: 9923651
[TBL] [Abstract][Full Text] [Related]
2. G76E substitution in type I collagen is the first nonlethal glutamic acid substitution in the alpha1(I) chain and alters folding of the N-terminal end of the helix.
Cabral WA; Chernoff EJ; Marini JC
Mol Genet Metab; 2001 Apr; 72(4):326-35. PubMed ID: 11286507
[TBL] [Abstract][Full Text] [Related]
3. Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagen.
Sarafova AP; Choi H; Forlino A; Gajko A; Cabral WA; Tosi L; Reing CM; Marini JC
Hum Mutat; 1998; 11(5):395-403. PubMed ID: 9600458
[TBL] [Abstract][Full Text] [Related]
4. Studies on type I collagen in skin fibroblasts cultured from twins with lethal osteogenesis imperfecta.
Galicka A; Wołczyński S; Gindzieński A
Acta Biochim Pol; 2003; 50(2):481-8. PubMed ID: 12833172
[TBL] [Abstract][Full Text] [Related]
5. Type I procollagens containing substitutions of aspartate, arginine, and cysteine for glycine in the pro alpha 1 (I) chain are cleaved slowly by N-proteinase, but only the cysteine substitution introduces a kink in the molecule.
Lightfoot SJ; Holmes DF; Brass A; Grant ME; Byers PH; Kadler KE
J Biol Chem; 1992 Dec; 267(35):25521-8. PubMed ID: 1460046
[TBL] [Abstract][Full Text] [Related]
6. A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain.
Valli M; Mottes M; Tenni R; Sangalli A; Gomez Lira M; Rossi A; Antoniazzi F; Cetta G; Pignatti PF
J Biol Chem; 1991 Jan; 266(3):1872-8. PubMed ID: 1988452
[TBL] [Abstract][Full Text] [Related]
7. Substitution of serine for glycine 883 in the triple helix of the pro alpha 1 (I) chain of type I procollagen produces osteogenesis imperfecta type IV and introduces a structural change in the triple helix that does not alter cleavage of the molecule by procollagen N-proteinase.
Lightfoot SJ; Atkinson MS; Murphy G; Byers PH; Kadler KE
J Biol Chem; 1994 Dec; 269(48):30352-7. PubMed ID: 7982948
[TBL] [Abstract][Full Text] [Related]
8. Type I collagen triplet duplication mutation in lethal osteogenesis imperfecta shifts register of alpha chains throughout the helix and disrupts incorporation of mutant helices into fibrils and extracellular matrix.
Cabral WA; Mertts MV; Makareeva E; Colige A; Tekin M; Pandya A; Leikin S; Marini JC
J Biol Chem; 2003 Mar; 278(12):10006-12. PubMed ID: 12538651
[TBL] [Abstract][Full Text] [Related]
9. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
[TBL] [Abstract][Full Text] [Related]
10. Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen.
Bateman JF; Chan D; Walker ID; Rogers JG; Cole WG
J Biol Chem; 1987 May; 262(15):7021-7. PubMed ID: 3108247
[TBL] [Abstract][Full Text] [Related]
11. A novel Gly to Arg substitution at position 388 of the alpha1 chain of type I collagen in lethal form of osteogenesis imperfecta.
Galicka A; Wolczynski S; Lesniewicz R; Chyczewski L; Gindzienski A
Acta Biochim Pol; 2002; 49(2):443-50. PubMed ID: 12362986
[TBL] [Abstract][Full Text] [Related]
12. A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.
Constantinou CD; Nielsen KB; Prockop DJ
J Clin Invest; 1989 Feb; 83(2):574-84. PubMed ID: 2913053
[TBL] [Abstract][Full Text] [Related]
13. A single base mutation that converts glycine 907 of the alpha 2(I) chain of type I procollagen to aspartate in a lethal variant of osteogenesis imperfecta. The single amino acid substitution near the carboxyl terminus destabilizes the whole triple helix.
Baldwin CT; Constantinou CD; Dumars KW; Prockop DJ
J Biol Chem; 1989 Feb; 264(5):3002-6. PubMed ID: 2914942
[TBL] [Abstract][Full Text] [Related]
14. Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite.
Culbert AA; Lowe MP; Atkinson M; Byers PH; Wallis GA; Kadler KE
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):815-20. PubMed ID: 7487936
[TBL] [Abstract][Full Text] [Related]
15. Substitution of an aspartic acid for glycine 700 in the alpha 2(I) chain of type I collagen in a recurrent lethal type II osteogenesis imperfecta dramatically affects the mineralization of bone.
Cohen-Solal L; Zylberberg L; Sangalli A; Gomez Lira M; Mottes M
J Biol Chem; 1994 May; 269(20):14751-8. PubMed ID: 8182080
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
[TBL] [Abstract][Full Text] [Related]
17. Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch.
Bateman JF; Moeller I; Hannagan M; Chan D; Cole WG
Hum Mutat; 1992; 1(1):55-62. PubMed ID: 1284475
[TBL] [Abstract][Full Text] [Related]
18. Canine COL1A2 mutation resulting in C-terminal truncation of pro-alpha2(I) and severe osteogenesis imperfecta.
Campbell BG; Wootton JA; Macleod JN; Minor RR
J Bone Miner Res; 2001 Jun; 16(6):1147-53. PubMed ID: 11393792
[TBL] [Abstract][Full Text] [Related]
19. Substitution of aspartic acid for glycine at position 310 in type II collagen produces achondrogenesis II, and substitution of serine at position 805 produces hypochondrogenesis: analysis of genotype-phenotype relationships.
Bonaventure J; Cohen-Solal L; Ritvaniemi P; Van Maldergem L; Kadhom N; Delezoide AL; Maroteaux P; Prockop DJ; Ala-Kokko L
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):823-30. PubMed ID: 7741714
[TBL] [Abstract][Full Text] [Related]
20. Biochemical screening of type I collagen in osteogenesis imperfecta: detection of glycine substitutions in the amino end of the alpha chains requires supplementation by molecular analysis.
Cabral WA; Milgrom S; Letocha AD; Moriarty E; Marini JC
J Med Genet; 2006 Aug; 43(8):685-90. PubMed ID: 16882741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
